Cargando…

Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial

BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Sanchez, Julia, Lewis, Gemma, Solmi, Francesca, Bone, Jessica K., Moore, Michael, Wiles, Nicola, Harmer, Catherine J., Duffy, Larisa, Lewis, Glyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600933/
https://www.ncbi.nlm.nih.gov/pubmed/36727498
http://dx.doi.org/10.1017/S0033291722003981
_version_ 1785126092206505984
author Rodriguez-Sanchez, Julia
Lewis, Gemma
Solmi, Francesca
Bone, Jessica K.
Moore, Michael
Wiles, Nicola
Harmer, Catherine J.
Duffy, Larisa
Lewis, Glyn
author_facet Rodriguez-Sanchez, Julia
Lewis, Gemma
Solmi, Francesca
Bone, Jessica K.
Moore, Michael
Wiles, Nicola
Harmer, Catherine J.
Duffy, Larisa
Lewis, Glyn
author_sort Rodriguez-Sanchez, Julia
collection PubMed
description BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse. METHODS: The ANTLER trial was a large (N = 478) pragmatic double-blind trial investigating the clinical effectiveness of long-term antidepressant treatment for preventing relapse in primary care patients. Participants were randomised to continue their maintenance antidepressants or discontinue via a taper to placebo. We analysed memory for positive and negative personality descriptors, assessed at baseline, 12- and 52-week follow-up. RESULTS: The recall task was completed by 437 participants. There was no evidence of an effect of discontinuation on self-referential recall at 12 [positive recall ratio 1.00, 95% CI (0.90–1.11), p = 0.93; negative recall ratio 1.00 (0.87–1.14), p = 0.87] or 52 weeks [positive recall ratio 1.03 (0.91–1.17), p = 0.62; negative recall ratio 1.00 (0.86–1.15), p = 0.96; ratios larger than one indicate higher recall in the discontinuation group], and no evidence of an association between recall at baseline or 12 weeks and later relapse [baseline, positive hazard ratio (HR) 1.02 (0.93–1.12), p = 0.74; negative HR 1.01 (0.90–1.13), p = 0.87; 12 weeks, positive HR 0.99 (0.89–1.09), p = 0.81; negative HR 0.98 (0.84–1.14), p = 0.78; ratios larger than one indicate a higher frequency of relapse in those with higher recall]. CONCLUSIONS: We found no evidence that discontinuing long-term antidepressants altered self-referential recall or that self-referential recall was associated with risk of relapse. These findings suggest that self-referential recall is not a neuropsychological marker of antidepressant action.
format Online
Article
Text
id pubmed-10600933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-106009332023-10-27 Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial Rodriguez-Sanchez, Julia Lewis, Gemma Solmi, Francesca Bone, Jessica K. Moore, Michael Wiles, Nicola Harmer, Catherine J. Duffy, Larisa Lewis, Glyn Psychol Med Original Article BACKGROUND: Antidepressants have been proposed to act via their influence on emotional processing. We investigated the effect of discontinuing maintenance antidepressant treatment on positive and negative self-referential recall and the association between self-referential recall and risk of relapse. METHODS: The ANTLER trial was a large (N = 478) pragmatic double-blind trial investigating the clinical effectiveness of long-term antidepressant treatment for preventing relapse in primary care patients. Participants were randomised to continue their maintenance antidepressants or discontinue via a taper to placebo. We analysed memory for positive and negative personality descriptors, assessed at baseline, 12- and 52-week follow-up. RESULTS: The recall task was completed by 437 participants. There was no evidence of an effect of discontinuation on self-referential recall at 12 [positive recall ratio 1.00, 95% CI (0.90–1.11), p = 0.93; negative recall ratio 1.00 (0.87–1.14), p = 0.87] or 52 weeks [positive recall ratio 1.03 (0.91–1.17), p = 0.62; negative recall ratio 1.00 (0.86–1.15), p = 0.96; ratios larger than one indicate higher recall in the discontinuation group], and no evidence of an association between recall at baseline or 12 weeks and later relapse [baseline, positive hazard ratio (HR) 1.02 (0.93–1.12), p = 0.74; negative HR 1.01 (0.90–1.13), p = 0.87; 12 weeks, positive HR 0.99 (0.89–1.09), p = 0.81; negative HR 0.98 (0.84–1.14), p = 0.78; ratios larger than one indicate a higher frequency of relapse in those with higher recall]. CONCLUSIONS: We found no evidence that discontinuing long-term antidepressants altered self-referential recall or that self-referential recall was associated with risk of relapse. These findings suggest that self-referential recall is not a neuropsychological marker of antidepressant action. Cambridge University Press 2023-10 2023-02-02 /pmc/articles/PMC10600933/ /pubmed/36727498 http://dx.doi.org/10.1017/S0033291722003981 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Original Article
Rodriguez-Sanchez, Julia
Lewis, Gemma
Solmi, Francesca
Bone, Jessica K.
Moore, Michael
Wiles, Nicola
Harmer, Catherine J.
Duffy, Larisa
Lewis, Glyn
Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title_full Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title_fullStr Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title_full_unstemmed Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title_short Neuropsychological markers of antidepressant action: a secondary analysis of the ANTLER randomised controlled trial
title_sort neuropsychological markers of antidepressant action: a secondary analysis of the antler randomised controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600933/
https://www.ncbi.nlm.nih.gov/pubmed/36727498
http://dx.doi.org/10.1017/S0033291722003981
work_keys_str_mv AT rodriguezsanchezjulia neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT lewisgemma neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT solmifrancesca neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT bonejessicak neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT mooremichael neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT wilesnicola neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT harmercatherinej neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT duffylarisa neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial
AT lewisglyn neuropsychologicalmarkersofantidepressantactionasecondaryanalysisoftheantlerrandomisedcontrolledtrial